Canada, India, Europe, America, China and Deepika

The Kush

Hi! Welcome to the 14th edition of The Kush, our newsletter written specifically for Mondays and Tuesdays. If you’re reading this for the first time, then welcome. We’re sitting out of Bengaluru as of this writing. Wherever you are reading this from, whenever you’ll read this, just remember one thing – this is the place where you will always get the clarity you seek. For it is clarity about the world that leads an individual to have a sense of control over his or her own life. 

Let’s start blazing. 

Canadian Indians Have Started-up to Make Cannabis infused Medicines 

While medical cannabis companies around the world strive to work with regulators pertaining to clinical trials and efficacy data, a cohort of companies have also emerged to make medicines for the complications associated with the coronavirus infection. For instance, many Covid-19 patients tend to develop complications in their lungs and hearts as a result of their own lifestyle and existing health issues if any.

We read some interesting news on Moneycontrol: 

“Akseera Pharma, a Canadian startup founded by entrepreneurs of Indian origin, is planning to begin clinical trials and manufacturing of Cannabidiol (CBD), a medicinal compound derived from Cannabis, in India. CBD will be used in a potential therapy for cardiac arrhythmias, or irregular heartbeat, with possible link to COVID-19.” 

We’ve read quite a lot about CBD, how it’s supposed to be non-psychoactive and apparently its cousin, THC is somehow always made out to be useful only for recreational purposes. We sincerely disagree with this. Not only is THC as important as CBD if not more important, such talk conveniently forgets the fact that other than THC and CBD, there are hordes of other 200 odd cannabinoids (Like CBG, CBC, THCV to name a few) which will definitely be useful for the welfare of human bodies. 

“CBD, which Akseera is planning to repurpose for COVID-19 treatment, is approved in many countries, including the US, to treat rare forms of childhood epilepsy or seizures such as Dravet Syndrome, for which traditional medicines don’t always work. The advantage of CBD is that it is not intoxicating.”

“We have pre-clinical data. We are ready for clinical trials,” said Manit Patel, Chief Executive Officer and Co-Founder, Akseera Pharma.

“CBD, which is our prime candidate, already has approvals in different countries for different conditions. So we are basically suggesting repurposing of the drug, just like azithromycin and hydroxychloroquine,” Patel added. Patel said Akseera is reaching out to the Drugs Controller General of India (DCGI), and if everything goes according to plan, CBD therapy for COVID-19 would be available in India before the end of this year. Akseera’s President and Co-Founder and Shreema Merchant says they are considering the drug for both adjunct as well as standalone therapy.” 

All the best Akseera! 

If you manage to pull this off (it’s an uphill battle), you’ll single-handedly turn the Indian media frenzy about cannabis into a national reawakening for medical cannabis. What will the media say then? 

Let’s keep blazing.

Europe is Caught Between America and China

Europe, known for being the cradle that birthed the scientific renaissance, that is the scientific enlightenment, which directly led to the industrial revolution in the UK in the 18th century, is today trying to understand how best it can insulate itself from both American and Chinese technology companies without pissing off either of them in the first place. It’s a tricky task, and in typical European fashion, they may well likely pull it off too. After all, what’s the worst that can happen? 

Here’s Natalia Drozdiak writing in from Brussels for Bloomberg Tech’s newsletter ‘Fully Charged’: 

“In its campaign to sideline Chinese companies like TikTok and Huawei Technologies Co., the U.S. has often found allies in Europe. Thanks to U.S. national security warnings, the European Union has at times taken a harsher stance toward Chinese technology than it otherwise would have. But EU officials are also treading cautiously around the tech policy of another geopolitical player—the U.S. itself.

Before we come to the crux of this global issue that has spread its tentacles everywhere (Including India obviously, the Indian government has banned some 200 odd apps made by Chinese developers), it is important to know where this situation even began. Remember Edward Snowden? Many do. 

“Tensions between Europe and the U.S. over data date back to 2013, when National Security Agency contractor Edward Snowden revealed the massive scope of American surveillance programs. The result was a severe breach of trust between Europe and the U.S. After the Snowden leaks, U.S. President Barack Obama’s administration moved to curb bulk data collection by intelligence agencies. Officials gave Europeans written assurances of privacy and attempted to set clear limits on data access. But the unease between the two world powers has lingered.

Trust is intangible. And at the end of the day, everything in the entire world works on trust. Personal or professional stuff. It’s actually about trusting the other person with regards to one thing fundamental to the human condition – will you harm me sometime in the future, and if so in what way, and what’re the chances of you doing that?

One solution for the EU is to try to avoid certain technology from both America and China. Germany, France and others are pushing ahead with plans for a “federated cloud,” dubbed Gaia-X. The project is an attempt to create a European alternative to U.S. cloud providers like Inc. or Microsoft Corp., which are required under the U.S. Cloud Act to grant authorities access to data even if it’s stored abroad.”

The European Union does not want to trust either the Americans (Facebook, Amazon and Microsoft) or the Chinese (primarily Huawei because of its 5G technology capabilities, and Bytedance which owns Tik Tok Global)

Let’s keep blazing. 

Move over Rhea C, it’s time for Deepika P 

Deepika Padukone may have apparently asked for cannabis and hash (a concentrated form of cannabis resin) from her manager and we haven’t even lifted our eyebrows. Blah, Blah, Blah and blah. 

Deepika P has been quite outspoken towards Indian media in general, and she’s no Rhea C. Will the Indian media treat her the same way as they did Rhea C? We don’t think so. Deepika P has more pull and in general, is a highly-acclaimed actress respected by millions. Our prediction is that, Deepika P would probably be as outspoken about cannabis as she has always been about many things. 

And we hope she is. 

Let’s keep blazing 🙂

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s